The performance of companies tied to Sildenafil's history presents a complex investment landscape. While the initial boom generated substantial gains, generic copies have significantly eroded revenue. https://knockoff858940.pointblog.net/copyright-s-flagship-product-and-big-pharma-a-uncertain-opportunity-94323844